However, Rebastinib almost completely diminished the CCM lesions induced by Ccm3 deletion as visualized by whole-brain imaging and H&E staining compared to vehicle treatment in Pdcd10BECKO mice (Fig. 7b with quantification in 7c). Here, PDCD10 is linked to cerebral cavernous malformation.